PURE · Pure Bioscience, Inc.
Market Cap
$11.70M
Shares
130.02M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.08
Open$0.06
Day$0.06–0.08
52W close$0.04–0.11
Avg vol 30d28K
Short int10K · 0.0% float · 1.0d
Short vol8%
DataJan 2020–Sep 2026
Filing10-Q · Jun 15
Up next
FQ1-27 quarter ends
~Oct 31, 2026
Est
filed Jun 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+26%
above
Price vs 50-day avg
+16%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
57%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+33%
trailing
6-month return
+33%
trailing
YTD return
+100%
this year
Relative strength
+21%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +30.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Squeeze score
32
low risk · 0–100
Fundamentals
Revenue growth
+12%
Y/Y
Gross margin
59%
expanding
EPS growth
+33%
Y/Y
Free cash flow
$-2.0M
Balance sheet
$1.3M
net cash
Quant / Vol
risk profile
Volatility
154%
annualized · 1-yr
Max drawdown
−64%
past year
ATR
19.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+26%
Bullish
Price vs 50-day avg
+16%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
57%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +30.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $0
Now $0 · 57%
Range high $0
vs 200-day avg +26%
vs 50-day avg +16%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PURE
this stock
Pure Bioscience, Inc.
|
$11.70M | +100.0% | +12.4% | — | 0.0% |
|
PG
PROCTER & GAMBLE Co
|
$334.21B | +2.0% | +3.3% | 21.7 | 1.1% |
|
UL
Unilever PLC
|
$140.11B | -1.6% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$72.64B | +13.4% | +1.7% | 36.0 | 2.2% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$44.56B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.6%
- Net QoQ
- +809.8K sh
- Top holder
- IFG Advisory, LLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PURE | +33.3% | +33.3% | +33.3% | +1.3% | +100.0% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | +33.9% | +34.6% | +20.7% | +2.0% | +88.3% |